10-K Filing

NEUROCRINE BIOSCIENCES INC CIK: 914475 FY 2019

Filing Information

Form Type	10-K
Accession Number	`0001564590-20-003773`
Period End Date	20191231
Filing Date	20200207
Fiscal Year	2019
Fiscal Period	FY
XBRL Instance	nbix-10k_20191231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 68 Income Statement 115 Cash Flow Statement 94 Stockholders Equity 34

Balance Sheet 68 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$112.28M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$141.71M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$558.25M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$509.20M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$57.41M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$126.58M	USD	Point-in-time
Inventory	`InventoryNet`	$10.86M	USD	Point-in-time
Inventory	`InventoryNet`	$17.29M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	220.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	220.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	92.27M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$18.59M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$16.65M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	90.80M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$831.03M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$737.78M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	92.27M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	90.80M	shares	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$216.03M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$299.65M	USD	Point-in-time
Operating lease assets	`OperatingLeaseRightOfUseAsset`	$74.36M	USD	Point-in-time
Restricted equity securities	`EquitySecuritiesFvNiRestricted`	$55.87M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$41.91M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$33.87M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$3.21M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$5.48M	USD	Point-in-time
Total assets	`Assets`	$1.31B	USD	Point-in-time
Total assets	`Assets`	$993.15M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$86.38M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$141.28M	USD	Point-in-time
Convertible senior notes	`ConvertibleDebtCurrent`	$408.81M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.86M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$15.20M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$88.23M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$565.29M	USD	Point-in-time
Convertible senior notes	`ConvertibleDebtNoncurrent`	$388.50M	USD	Point-in-time
Convertible senior notes	`ConvertibleDebtNoncurrent`	$408.81M	USD	Point-in-time
Noncurrent operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$86.76M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$17.07M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$35.66M	USD	Point-in-time
Total liabilities	`Liabilities`	$512.39M	USD	Point-in-time
Total liabilities	`Liabilities`	$669.12M	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 220,000 shares authorized; issued and outstanding shares were 92,272 and 90,797 at December 31, 2019 and 2018, respectively	`CommonStockValue`	$92.00K	USD	Point-in-time
Common stock, $0.001 par value; 220,000 shares authorized; issued and outstanding shares were 92,272 and 90,797 at December 31, 2019 and 2018, respectively	`CommonStockValue`	$91.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.66B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.77B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.93M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.41M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.18B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.13B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$372.14M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$314.88M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$636.92M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$480.76M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.31B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$993.15M	USD	Point-in-time

Income Statement 115 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$244.01M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$451.24M	USD	Annual
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$151.76M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$222.09M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$138.40M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$96.91M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$71.09M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$131.49M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$183.58M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$161.63M	USD	Annual
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$788.09M	USD	Annual
Cost of sales	`CostOfSales`	$4.89M	USD	Annual
Cost of sales	`CostOfSales`	$7.43M	USD	Annual
Cost of sales	`CostOfSales`	$1.25M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$91.83M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$200.04M	USD	Annual
Research and development	`ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$155.77M	USD	Annual
Acquired in-process research and development	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$4.75M	USD	Annual
Acquired in-process research and development	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$154.27M	USD	Annual
Acquired in-process research and development	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$30.00M	USD	Annual
Sales, general and administrative	`SellingGeneralAndAdministrativeExpense`	$169.91M	USD	Annual
Sales, general and administrative	`SellingGeneralAndAdministrativeExpense`	$354.06M	USD	Annual
Sales, general and administrative	`SellingGeneralAndAdministrativeExpense`	$248.93M	USD	Annual
Total operating expenses	`OperatingExpenses`	$239.40M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$109.62M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$149.12M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$414.35M	USD	Annual
Total operating expenses	`OperatingExpenses`	$132.00M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$108.53M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$97.43M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$195.29M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$715.80M	USD	Annual
Total operating expenses	`OperatingExpenses`	$292.99M	USD	Annual
Total operating expenses	`OperatingExpenses`	$98.76M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$-131.36M	USD	Annual
Operating income (loss)	`OperatingIncomeLoss`	$36.90M	USD	Annual
Operating income (loss)	`OperatingIncomeLoss`	$72.28M	USD	Annual
Interest expense	`InterestExpense`	$31.96M	USD	Annual
Interest expense	`InterestExpense`	$19.52M	USD	Annual
Interest expense	`InterestExpense`	$30.53M	USD	Annual
Unrealized loss on restricted equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	-	USD	Annual
Unrealized loss on restricted equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	-	USD	Annual
Unrealized loss on restricted equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	$-12.99M	USD	Annual
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$15.48M	USD	Annual
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$8.34M	USD	Annual
Investment income and other, net	`InvestmentIncomeAndOtherNet`	$19.21M	USD	Annual
Total other expense, net	`NonoperatingIncomeExpense`	$-15.05M	USD	Annual
Total other expense, net	`NonoperatingIncomeExpense`	$-25.74M	USD	Annual
Total other expense, net	`NonoperatingIncomeExpense`	$-11.18M	USD	Annual
Income (loss) before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-142.54M	USD	Annual
Income (loss) before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$21.84M	USD	Annual
Income (loss) before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$46.54M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$730.00K	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$9.53M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$34.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$51.34M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$50.76M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-41.82M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-5.91M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-102.11M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$18.08M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$21.11M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$37.01M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$53.79M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-142.54M	USD	Annual
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-82.00K	USD	Annual
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$3.35M	USD	Annual
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.53M	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$40.36M	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-144.07M	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$21.03M	USD	Annual
Net income (loss) per share, basic	`EarningsPerShareBasic`	$0.56	USD	1 Quarter
Net income (loss) per share, basic	`EarningsPerShareBasic`	$0.40	USD	Annual
Net income (loss) per share, basic	`EarningsPerShareBasic`	$0.56	USD	1 Quarter
Net income (loss) per share, basic	`EarningsPerShareBasic`	$0.23	USD	Annual
Net income (loss) per share, basic	`EarningsPerShareBasic`	$0.37	USD	1 Quarter
Net income (loss) per share, basic	`EarningsPerShareBasic`	$-0.07	USD	1 Quarter
Net income (loss) per share, basic	`EarningsPerShareBasic`	$-1.12	USD	1 Quarter
Net income (loss) per share, basic	`EarningsPerShareBasic`	$0.20	USD	1 Quarter
Net income (loss) per share, basic	`EarningsPerShareBasic`	$0.59	USD	1 Quarter
Net income (loss) per share, basic	`EarningsPerShareBasic`	$-0.47	USD	1 Quarter
Net income (loss) per share, basic	`EarningsPerShareBasic`	$-1.62	USD	Annual
Net income (loss) per share, diluted	`EarningsPerShareDiluted`	$0.35	USD	1 Quarter
Net income (loss) per share, diluted	`EarningsPerShareDiluted`	$-0.07	USD	1 Quarter
Net income (loss) per share, diluted	`EarningsPerShareDiluted`	$0.19	USD	1 Quarter
Net income (loss) per share, diluted	`EarningsPerShareDiluted`	$-1.12	USD	1 Quarter
Net income (loss) per share, diluted	`EarningsPerShareDiluted`	$0.56	USD	1 Quarter
Net income (loss) per share, diluted	`EarningsPerShareDiluted`	$0.22	USD	Annual
Net income (loss) per share, diluted	`EarningsPerShareDiluted`	$0.39	USD	Annual
Net income (loss) per share, diluted	`EarningsPerShareDiluted`	$-0.47	USD	1 Quarter
Net income (loss) per share, diluted	`EarningsPerShareDiluted`	$-1.62	USD	Annual
Net income (loss) per share, diluted	`EarningsPerShareDiluted`	$0.54	USD	1 Quarter
Net income (loss) per share, diluted	`EarningsPerShareDiluted`	$0.52	USD	1 Quarter
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	88.09M	shares	Annual
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	91.06M	shares	1 Quarter
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	90.74M	shares	1 Quarter
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	91.86M	shares	1 Quarter
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	92.18M	shares	1 Quarter
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	89.53M	shares	1 Quarter
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	90.23M	shares	Annual
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	91.39M	shares	1 Quarter
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	90.56M	shares	1 Quarter
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	90.10M	shares	1 Quarter
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	91.63M	shares	Annual
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	96.80M	shares	1 Quarter
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	96.07M	shares	1 Quarter
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	90.10M	shares	1 Quarter
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	94.78M	shares	1 Quarter
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	89.53M	shares	1 Quarter
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	95.39M	shares	Annual
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	91.06M	shares	1 Quarter
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	97.23M	shares	1 Quarter
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	95.73M	shares	Annual
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	88.09M	shares	Annual
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	95.72M	shares	1 Quarter

Cash Flow Statement 94 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$34.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$51.34M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$50.76M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-41.82M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-5.91M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-102.11M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$18.08M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$21.11M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$37.01M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$53.79M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-142.54M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$75.26M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$58.07M	USD	Annual
Share-based compensation expense	`ShareBasedCompensation`	$42.52M	USD	Annual
Depreciation	`Depreciation`	$7.45M	USD	Annual
Depreciation	`Depreciation`	$2.40M	USD	Annual
Depreciation	`Depreciation`	$4.02M	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$17.55M	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$10.94M	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$18.92M	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$1.39M	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$1.33M	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$848.00K	USD	Annual
Net (accretion of discounts) amortization of premiums on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$1.97M	USD	Annual
Net (accretion of discounts) amortization of premiums on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.76M	USD	Annual
Net (accretion of discounts) amortization of premiums on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.45M	USD	Annual
Change in fair value of restricted equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	-	USD	Annual
Change in fair value of restricted equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	-	USD	Annual
Change in fair value of restricted equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	$-12.99M	USD	Annual
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$754.00K	USD	Annual
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$-1.45M	USD	Annual
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$-409.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$25.11M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$69.17M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$31.13M	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$3.52M	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$6.42M	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$1.02M	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$27.34M	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$53.95M	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$24.22M	USD	Annual
Other changes in operating assets and liabilities, net	`IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet`	$-21.88M	USD	Annual
Other changes in operating assets and liabilities, net	`IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet`	$3.99M	USD	Annual
Other changes in operating assets and liabilities, net	`IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet`	$-2.66M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-94.33M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$101.36M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$152.05M	USD	Annual
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$545.96M	USD	Annual
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$583.41M	USD	Annual
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$797.17M	USD	Annual
Sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$339.09M	USD	Annual
Sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$327.82M	USD	Annual
Sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$669.69M	USD	Annual
Purchase of restricted equity securities	`PaymentsToAcquireRestrictedInvestments`	$68.86M	USD	Annual
Purchase of restricted equity securities	`PaymentsToAcquireRestrictedInvestments`	-	USD	Annual
Purchase of restricted equity securities	`PaymentsToAcquireRestrictedInvestments`	-	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$6.94M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$14.75M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$24.81M	USD	Annual
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$8.00K	USD	Annual
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$7.00K	USD	Annual
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$34.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-242.91M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-251.25M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-211.07M	USD	Annual
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$13.87M	USD	Annual
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$29.53M	USD	Annual
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$27.31M	USD	Annual
Proceeds from issuance of convertible senior notes, net	`ProceedsFromConvertibleDebt`	-	USD	Annual
Proceeds from issuance of convertible senior notes, net	`ProceedsFromConvertibleDebt`	-	USD	Annual
Proceeds from issuance of convertible senior notes, net	`ProceedsFromConvertibleDebt`	$502.78M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$29.53M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$27.31M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$516.65M	USD	Annual
Change in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$171.06M	USD	Annual
Change in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-112.02M	USD	Annual
Change in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-31.71M	USD	Annual
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$147.19M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$88.15M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$115.48M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$259.21M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$147.19M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$88.15M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$115.48M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$259.21M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$11.64M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$11.64M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$6.24M	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaid`	$507.00K	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	Annual
Non-cash capital expenditures	`CapitalExpendituresIncurredButNotYetPaid`	-	USD	Annual
Non-cash capital expenditures	`CapitalExpendituresIncurredButNotYetPaid`	$953.00K	USD	Annual
Non-cash capital expenditures	`CapitalExpendituresIncurredButNotYetPaid`	$2.32M	USD	Annual

Stockholders Equity 34 line items

Line Item	Tag	Value	Unit	Period
Begining balance	`StockholdersEquity`	$372.14M	USD	Point-in-time
Begining balance	`StockholdersEquity`	$314.88M	USD	Point-in-time
Begining balance	`StockholdersEquity`	$636.92M	USD	Point-in-time
Begining balance	`StockholdersEquity`	$480.76M	USD	Point-in-time
Net income (loss)	`NetIncomeLoss`	$34.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$51.34M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$50.76M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-41.82M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-5.91M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-102.11M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$18.08M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$21.11M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$37.01M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$53.79M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-142.54M	USD	Annual
Unrealized gain (loss) on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-82.00K	USD	Annual
Unrealized gain (loss) on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$3.35M	USD	Annual
Unrealized gain (loss) on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-1.53M	USD	Annual
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$75.26M	USD	Annual
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$42.52M	USD	Annual
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$58.07M	USD	Annual
Issuance of common stock for vested restricted stock units	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.00K	USD	Annual
Issuance of common stock for stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$29.53M	USD	Annual
Issuance of common stock for stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$27.31M	USD	Annual
Issuance of common stock for stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$13.86M	USD	Annual
Issuance of common stock for stock option exercises (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	1.35M	shares	Annual
Issuance of common stock for stock option exercises (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	983,000.00	shares	Annual
Issuance of common stock for stock option exercises (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	1.59M	shares	Annual
Equity component of convertible debt, net	`AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt`	$144.95M	USD	Annual
Issuance of common stock for employee stockpurchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$5.18M	USD	Annual
Ending balance	`StockholdersEquity`	$372.14M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$314.88M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$636.92M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$480.76M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.